- B.S., University of Florida
- Ph.D., University of Florida
In the Lab
Efforts to develop stroke treatments have met with limited success despite an intense need to produce novel treatments. The failed translation of many of these therapies in clinical trials has lead to a close examination of the therapeutic development process. One of the major factors believed to be limiting effective screening of these treatments is the absence of an animal model more predictive of human responses to treatments. The pig may potentially fill this gap with a gyrencephalic brain that is larger in size with a more similar gray-white matter composition to humans than traditional stroke animal models. In this study we develop and characterize a novel pig middle cerebral artery occlusion (MCAO) ischemic stroke model…. Read More
- biomechanics in response to disease/treatment, particularly pertaining to stroke and brain injury
- Publications by Dr. Duberstein may be found at PubMed.